Investors |


LexaGene in Boston Herald

LexaGene CEO Dr. Jack Regan quoted as a virologist and influenza expert in the Boston Herald on the challenges of self-quarantine measures during the 2019 coronavirus outbreak.

Read More

LexaGene local coverage: Coronavirus

Read local coverage of LexaGene’s development of a genetic analyzer to detect viruses like coronavirus.

Read More

Coronavirus news recap

LexaGene CEO and Founder Dr. Jack Regan explains the threat of the current coronavirus outbreak and recaps LexaGene’s latest news describing the company’s role in preventing the spread of pathogens like coronavirus.

Watch now

Cleanroom Technology article

Shortcomings in traditional culture testing leave the cannabis industry in search of methods that can enumerate or count the presence of microbes whether dead or alive. LexaGene CEO Dr. Jack Regan presents an alternative in the Cleanroom Technology article on LexaGene’s DNA-driven pathogen detection for cannabis-hemp products.

Read More

Forbes features LexaGene: Next big breakthrough

This Forbes full-length feature on LexaGene and our technology describes how LexaGene could be the next big medical breakthrough. > Read now.

Read More

LexaGene introduced in Forbes

LexaGene was mentioned in this Forbes article as a solution provider tackling the challenge of improving food safety and reducing recalls.

Read More

Digital Journal Antibiotic Resistance Q&A

Digital Journal sits down with LexaGene CEO Dr. Regan to discuss the challenge of antibiotic resistance threats and how LexaGene’s LX Analyzer can help improve antibiotic stewardship.

Read More

Investing News Coverage

LexaGene CEO Dr. Jack Regan talks with Investing news about post-raise plans for commercialization.

Read More

LexaGene Stock Day Podcast

LexaGene joins The Stock Day Podcast to discuss the company’s commercialization of the LX Genetic Analyzer.

Read More

LexaGene in Cleanroom Technology

LexaGene’s beta installation at CDX cannabis testing facilities featured in Cleanroom Technology. The article describes how LexaGene is bringing better detection to the cannabis testing market.

Read More

Boston Business Journal article

Boston Business Journal featured LexaGene in a story about how the company is trying to tackle possible under-reporting of EEE virus.

Read More

LexaGene featured on CBS Boston 4

LexaGene was featured on CBS Boston 4 WBZ during the news reporting of the EEE virus outbreak in Massachusetts
and other states.

Watch video